Kimberly Futch
Senior Director, Clinical Operations Tanabe Pharma
Kim has 20+ years of clinical experience and more than 18 years of dedicated to oncology drug development. Kim’s background includes program and project management, operational execution, client relationship management and strategy formulation.
She has Phase I –IV trial experience ranging from first in human trials through successful NDA submissions in large pharma, biotechs and CROs.
Additional areas of therapeutic experience include, CNS, Immunology, Infectious Disease and Rare Disease. Kim holds a BS in Neuroscience from Lafayette College and an MBA in Pharmaceutical Business from the Philadelphia College of Pharmacy.
Seminars
Wednesday 18th November 2026
From Last Resort to Standard of Care, Lessons from Oncology on Integrating Clinical Trial Discussions Earlier in the Patient Journey
2:45 pm
- Explore how oncology has successfully positioned clinical trials as an integral part of care rather than a final treatment option, increasing patient awareness and participation
- Examine the patient engagement, navigation, and education models that have helped normalize clinical trial discussions throughout the care journey
- Identify which oncology recruitment approaches can be adapted across rare disease and other therapeutic areas to improve patient access and enrollment outcomes
